Comments
Loading...
Novavax (NASDAQ:NVAX) Stock Quotes, Forecast and News Summary
Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Novavax (NVAX) stock?
You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.
Who are Novavax (NVAX) competitors?
Other companies in Novavax’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB), Cogent Biosciences (NASDAQ:COGT) and Syndax Pharmaceuticals (NASDAQ:SNDX).
What is the forecast, or price target, for Novavax (NVAX) stock?
Novavax has a consensus price target of $48.13.
What is the current price for Novavax (NVAX)?
The stock price for Novavax (NASDAQ: NVAX) is $7.65 last updated November 14, 2024 at 3:00 PM EST.
Does Novavax (NVAX) pay a dividend?
There are no upcoming dividends for Novavax.
When is Novavax (NASDAQ:NVAX) reporting earnings?
Novavax’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Novavax (NVAX) going to split?
There is no upcoming split for Novavax.
What sector and industry does Novavax (NVAX) operate in?
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.